400 cps per part per million of total Pb. The ion probe analyses reproduced the TIMS value within Ͻ0.1% standard errors (2, n ϭ 35). The mass fractionation for SIMS analysis was Ͻ0.15% per atomic mass unit and was smaller than the in-run precision. 
Tankyrase, a Poly(ADP-Ribose)
Polymerase at Human Telomeres Susan Smith, Izabela Giriat, Anja Schmitt,* Titia de Lange † Tankyrase, a protein with homology to ankyrins and to the catalytic domain of poly(adenosine diphosphate-ribose) polymerase (PARP), was identified and localized to human telomeres. Tankyrase binds to the telomeric protein TRF1 (telomeric repeat binding factor-1), a negative regulator of telomere length maintenance. Like ankyrins, tankyrase contains 24 ankyrin repeats in a domain responsible for its interaction with TRF1. Recombinant tankyrase was found to have PARP activity in vitro, with both TRF1 and tankyrase functioning as acceptors for adenosine diphosphate (ADP)-ribosylation. ADP-ribosylation of TRF1 diminished its ability to bind to telomeric DNA in vitro, suggesting that telomere function in human cells is regulated by poly(ADP-ribosyl)ation.
Human telomere function requires two telomere-specific DNA binding proteins, TRF1 and TRF2 (1, 2) . TRF2 protects chromosome ends (3) , and TRF1 regulates telomere length (4) . Overexpression of TRF1 in a telomerase-expressing cell line leads to progressive telomere shortening, whereas inhibition of TRF1 increases telomere length (4). TRF1 does not control the expression of telomerase itself but is thought to act in cis by inhibiting telomerase at telomere termini.
To identify additional telomere-associated proteins, we used a yeast two-hybrid screen with human TRF1 as bait (5, 6 ). This screen yielded two overlapping partial cDNAs (TR1L-4 and TR1L-12) (Fig. 1A) . A full-length testis cDNA isolated with TR1L-4 encoded an open reading frame of 1327 amino acids, predicting a protein of 142 kD (Fig. 1A) (7) . The central domain of this protein contains 24 ankyrin (ANK) repeats, a 33-amino acid motif that mediates protein-protein interactions (8), and its COOH-terminal region has homology to the catalytic domain of PARP, a highly conserved nuclear enzyme found in most eukaryotes (9). We therefore named the protein tankyrase (TRF1-interacting, ankyrin-related ADP-ribose polymerase).
The tankyrase-interacting domain in TRF1 was identified by two-hybrid analysis (6) with TR1L-12 (Fig. 1A) . The tankyrase fragment, consisting of 10 ANK repeats, interacted with full-length TRF1 but not with a TRF1 mutant lacking the NH 2 -terminal acidic domain of TRF1 (Fig. 1B) . Consistent with this observation, significant interaction occurred with the isolated NH 2 -terminal 68 amino acids of TRF1, which encompass the acidic domain (Fig. 1B) . These results indicate that the acidic domain of TRF1 is necessary and sufficient for interaction with tankyrase. This domain is absent from TRF2, and a two-hybrid analysis (6) indicated that tankyrase does not interact with TRF2.
Three observations suggested that tankyrase was a member of the ankyrin family, a group of structural proteins that link integral membrane proteins to the underlying cytoskeleton (10). First, tankyrase, like all ankyrins, contained 24 copies of the ANK motif, whereas other ANK repeat-containing proteins typically have 4 to 8 repeats. Second, the ANK repeats in tankyrase and the ankyrins shared characteristic sequence features, such as the presence of a hydrophobic amino acid at position 3 and an Asn or a Asp at position 29 ( Fig. 2A) . Third, the fifth ANK copy in tankyrase was notably shorter than all others, a feature also observed in ankyrins. Apart from the ANK repeat domain, however, there was no detectable homology between tankyrase and ankyrins. The ankyrin domain of tankyrase is flanked at the NH 2 -terminus by a region carrying homopolymeric His, Ser, and Pro tracts and at the COOH-terminus by a sterile alpha module (SAM) motif (Fig. 2B) , which is postulated to function in protein-protein interaction (11).
The most striking feature of tankyrase is the homology to PARP. In response to DNA dam- age, PARP catalyzes the formation of poly-(ADP-ribose) onto a protein acceptor using nicotinamide adenine dinucleotide (NAD ϩ ) as a substrate (9). The catalytic domain of PARP consists of secondary structure units (multiple ␤ strands and one ␣ helix) (Fig. 2C ) that form a cavity known as the NAD ϩ -binding fold, a tertiary structure that is also present in all ADPribosylating toxins (12). Tankyrase has 28 to 30% amino acid identity with the catalytic domains of human and Drosophila PARP (Fig. 2C) , including all critical amino acids implicated in NAD ϩ binding and catalysis. Other conserved aspects of the previously defined PARPs such as their automodification and DNA binding domains (9) are not represented in tankyrase, indicating that tankyrase is not just a PARP isoform but a substantially different protein.
Northern (RNA) blot analysis revealed that multiple tankyrase mRNAs (13) were ubiquitously expressed in human tissues, with the highest amounts detectable in testis (Fig. 3A) . TRF1 and TRF2 transcripts show a similar ubiquitous expression pattern (1, 2) . A single protein of ϳ142 kD was detected by tankyrase immunoblot analysis of HeLa cells and rat testis, and this protein comigrated with the in vitro translation product of tankyrase cDNA ( Because TRF1 is predominantly associated with telomeres in human cells, including the telomeres of mitotic chromosomes, we used indirect immunofluorescence analysis of metaphase chromosomes to determine whether TRF1 positions tankyrase at chromosome ends. Metaphase spreads were dually probed with anti-tankyrase and antiserum to TRF1 (16). The results revealed that, like TRF1, tankyrase is located at or near the physical ends of metaphase chromosomes (Fig. 3C) . Most of the tankyrase protein colocalized with TRF1, as evidenced by the merge of the two signals. These data suggest that tankyrase is a component of the human telomeric complex.
To investigate whether tankyrase has PARP activity, we tested baculovirus-derived recombinant protein in an assay that measures the addition of radiolabeled ADP-ribose to protein acceptors
P-labeled species that comigrated with tankyrase, suggesting that tankyrase has the ability to ADP-ribosylate itself (Fig. 4A) . Higher concentrations of NAD ϩ (0.04 to 1 mM) yielded much larger products, likely reflecting the addition of poly(ADP-ribose) to tankyrase. The generation of ADP-ribosylated tankyrase depended on the concentration of tankyrase (Fig. 4A) , was eliminated by heat inactivation of the enzyme, and could be immunoprecipitated with antitankyrase (Fig. 4B) (18) , indicating that the PARP activity was intrinsic to tankyrase.
Tankyrase also has the ability to modify TRF1. At low NAD ϩ concentration (1.3 M), the ADP-ribosylated products comigrated with TRF1, whereas at higher NAD ϩ concentrations (0.04 to 1 mM), the slower and variable mobility of the labeled products suggested poly-(ADP-ribosyl)ation of TRF1 (Fig. 4A) . Inspection of Coomassie blue-stained SDS gels did not reveal a larger molecular weight species upon tankyrase-mediated TRF1 modification, indicating that only a small fraction of the TRF1 in the reactions was modified even at high tankyrase concentrations. Thus, tankyrase is likely to function as a processive PARP under these conditions. TRF2 is not a substrate for modification in vitro, as expected from the lack of protein-protein interaction between TRF2 and tankyrase.
To confirm that the labeling reaction with tankyrase was analogous to PARP-catalyzed poly(ADP-ribosyl)ation, we added the specific PARP inhibitor 3-aminobenzamide (3AB) to the reactions (19) . Modification of both TRF1 and tankyrase was strongly inhibited by 3AB (Fig. 4C) . Furthermore, modified tankyrase and TRF1 reacted with a monoclonal antibody to poly(ADP-ribose) (Fig. 4D ) (17) , consistent with their carrying ADPribose polymers. These data indicate that tankyrase is a genuine PARP with at least two specific substrates, TRF1 and tankyrase itself.
The effect of tankyrase on the telomeric DNA binding activity of TRF1 was determined by an in vitro gel-shift assay with the use of a double-stranded array of [TTAGGG] 12 as a probe (20) . TRF1 binds to DNA as a homodimer, and several such dimers can occupy one [TTAGGG] 12 molecule at high TRF1 concentrations (6) (Fig. 4E) . When TRF1 was incubated with baculovirus-derived tankyrase in the absence of NAD ϩ , a slight stimulation of the TRF1 DNA binding activity occurred, resulting in the formation of higher order complexes, especially at high tankyrase concentrations. However, this stimulation of TRF1 also occurred with total insect cell protein and was therefore unlikely to represent a specific effect of tankyrase. A similar nonspecific enhancement of TRF1 was previously reported for ␤-casein and several other proteins (1). In contrast, when NAD ϩ was included in the TRF1-tankyrase mixtures, a reduction of the TRF1 activity resulted (Fig. 4E) . This effect was dependent on the addition of active tankyrase (Fig. 4E) , consistent with ADP-ribosylation being the cause of the TRF1 inhibition.
The identification of a telomeric PARP rais- es the possibility that the function of human telomeres is regulated by this type of protein modification. Because ADP-ribosylation usually inhibits protein activity (21), we favor the view that tankyrase is a negative regulator of another factor acting at telomeres. Although the in vivo targets of tankyrase remain to be established, TRF1 is a strong candidate, because it is a substrate for tankyrase in vitro and ADPribosylation inhibits the ability of TRF1 to bind to telomeric DNA. However, the PARP activity of tankyrase could also be directed at other telomere-associated factors, including telomerase, and ADP-ribosylation might enhance rather than inhibit the activity of the target protein (22) . In vivo functional analysis will be required to determine whether tankyrase acts positively or negatively in the regulation of telomere length. PARPs have previously been implicated in the cellular response to DNA damage (9). The presence of a PARP activity at telomeres may also hint at a role for tankyrase in the protection of telomeres from inappropriate DNA damage processing activities. First, two overlapping cDNAs, 32 and 21, encompassing 8901 nt encoding amino acids 235 to 1327 were isolated from a HeLa cDNA library that had been probed with a polymerase chain reaction product (representing amino acids 973 to 1163) made from TR1L-4. The 5Ј end sequence was extended by rapid amplification of cDNA ends (RACE) and then used to screen a human testis library (Stratagene, La Jolla, CA). Analysis of two other testis library isolates, T T7 and T T9 (GenBank accession numbers AF082558 and AF082559), indicated that they were similar to T T20 along their length, but each had an insertion of ϳ100 13. The tankyrase cDNA TR1L-4 hybridized to three mRNAs of ϳ6, 8, and 10 kb with the same ubiquitous expression pattern. Testis express two additional transcripts, a 2.5-kb species and an abundant 4.5-kb species. The 4.2-kb T T20 tankyrase cDNA isolated from the testis library is large enough to represent the 4.5-kb transcript, suggesting that this cDNA is nearly full length.
The larger transcripts present in most tissues may be due to longer 3Ј untranslated regions (UTRs) because sequence analysis of a tankyrase cDNA from a HeLa cell library revealed the same sequence as the full-length 4.5-kb cDNA, but with an additional 5 kb of 3Ј UTR. When the most 3Ј 1 kb of this cDNA was used as a probe in a Northern blot, it hybridized exclusively to the largest (10-kb) transcript. 14. For immunoblots, HeLa cells were suspended directly in Laemmli loading buffer and loaded at ϳ50,000 cells per lane. Crude nuclei were isolated from rat testis (after hypotonic lysis), extracted with 0.4 M KCl, pelleted, and suspended in Laemmli buffer. In vitro-translated tankyrase was generated with a coupled transcriptiontranslation reticulocyte lysate system (Promega). A 1-g amount of T T20 was incubated with T3 RNA polymerase under standard conditions, and 10% of the reaction was loaded per lane. Protein samples were fractionated on SDS-polyacrylamide gels, transferred to nitrocellulose, and blocked in 5% milk in phosphate-buffered saline (PBS) containing 0.1% Tween-20. Antibody incubations were in 1% milk in PBS containing 0.1% Tween-20. Blots were first incubated with rabbit antibody to tankyrase (4 g/ml) or rabbit preimmune serum (1: 500) and then with horseradish peroxidase-conjugated donkey antibody to rabbit immunoglobulin G (IgG) (Amersham) (1: 2500). Bound antibody was detected by enhanced chemiluminescence (Amersham). For generation of antibody to tankyrase (antitankyrase), the Ank2 fragment representing amino acids 973 to 1149 of tankyrase was fused to vector pET-22b(ϩ) (Novagen) and expressed in Escherichia coli. The protein was isolated in inclusion bodies and used to immunize one rabbit. The resulting immune serum, rabbit anti-tankyrase 465, was affinity purified against Ank2 protein coupled to CnBr-activated Sepharose (Sigma). 15. Tankyrase protein was detected by protein immunoblot analysis in the following human cell lines: 293, transformed embryonic kidney cells; IMR90 and WI38, primary lung fibroblasts; WI38 VA13/2RA, immortalized lung fibroblasts; GM847, SV-40 -immortalized fibroblasts; Daudi and Raji, lymphoma; HT1080, fibrosarcoma; and MCF7, breast adenocarcinoma. Several of these cell lines expressed only the larger set of tankyrase mRNAs (6 to 10 kb), indicating that the 142-kD polypeptide can be expressed from one of these transcripts. 16. For chromosome spreads, HeLa cells were treated with colcemide (0.5 g/ml, 60 min), harvested by trypsinization, hypotonically swollen in 10 mM tris-HCl (pH 7.4), 10 mM NaCl, and 5 mM MgCl 2 , and sedimented onto cover slips for 15 s at 3000 rpm in a Sorvall RT6000B centrifuge. Chromosomes were swollen for 15 min in 25% PBS, fixed in 3.7% formaldehyde in 25% PBS for 10 min, and permeabilized with 0.5% NP-40 in 25% PBS for 10 min. Samples were blocked with 1% bovine serum albumin (BSA) in PBS, and then incubated with rabbit anti-tankyrase (1 g/ml) and a mouse polyclonal serum to full-length baculovirus-derived TRF1
